Stellar Biotechnologies, Inc.

based north of los angeles at the port of hueneme, stellar biotechnologies, inc. (nasdaq: sbot) is the leader in sustainable manufacture of keyhole limpet hemocyanin (klh), an important immune-stimulating protein used in wide-ranging therapeutic and diagnostic markets. klh is both an active pharmaceutical ingredient (api) in many new immunotherapies (targeting cancer, immune disorders, alzheimer's and inflammatory diseases) as well as a finished product for measuring immune status. stellar is unique in its proprietary methods, facilities, and klh technology. we are committed to meeting the growing demand for commercial-scale supplies of gmp grade klh, ensuring environmentally sound klh production, and developing klh-based active immunotherapies. stellar klh™ and powering and improving immunotherapy™ are trademarks of stellar biotechnologies, inc.